Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants

Clinical trial NCT04095286 · COMPLETED

Trial details

NCT number: NCT04095286
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2019-09-30
Primary completion: 2019-12-17
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.